Erik Mogalian
- Hepatology top 2%
- Epidemiology top 10%
- Infectious Diseases top 10%
- Pulmonary and Respiratory Medicine
- Molecular Biology
- Co-authors
- Anita MathiasDiana M. BrainardPolina GermanPaul B. MyrdalJohn McNallyJohn G. McHutchisonKimberly L. GarrisonBrian Doehle
- Topics
- Hepatitis C virus research (14 papers)HIV/AIDS drug development and treatment (8 papers)Inhalation and Respiratory Drug Delivery (5 papers)
- Journals
- Annals of Internal MedicineClinical Infectious DiseasesAntimicrobial Agents and Chemotherapy
- Partner nations
- United StatesAustraliaNew Zealand
In The Last Decade
Erik Mogalian
28 papers receiving 498 citations
Peers
Comparison fields: 5 of 75
- Hepatology 350
- Epidemiology 313
- Infectious Diseases 154
- Pulmonary and Respiratory Medicine 43
- Molecular Biology 33
Countries citing papers authored by Erik Mogalian
This map shows the geographic impact of Erik Mogalian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Mogalian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Mogalian more than expected).
Fields of papers citing papers by Erik Mogalian
This network shows the impact of papers produced by Erik Mogalian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Mogalian. The network helps show where Erik Mogalian may publish in the future.
Co-authorship network of co-authors of Erik Mogalian
This figure shows the co-authorship network connecting the top 25 collaborators of Erik Mogalian. A scholar is included among the top collaborators of Erik Mogalian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Mogalian. Erik Mogalian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 4 | |
| 3 | 5 | |
| 4 | 19 | |
| 5 | 9 | |
| 6 | 51 | |
| 7 | Safety and efficacy of treatment with once-daily ledipasvir/sofosbuvir (90/400 mg) for 12 weeks in genotype 1 hcv-infected patients with severe renal impairment. | 13 |
| 8 | 32 | |
| 9 | 102 | |
| 10 | 41 | |
| 11 | 66 | |
| 12 | 6 | |
| 13 | 27 | |
| 14 | 6 | |
| 15 | 11 | |
| 16 | 3 | |
| 17 | 4 | |
| 18 | 8 | |
| 19 | 16 | |
| 20 | 14 |
About Erik Mogalian
Erik Mogalian is a scholar working on Hepatology, Infectious Diseases and Genetics, having authored 29 papers that have together received 525 indexed citations. Recurring topics across this work include Hepatitis C virus research (14 papers), HIV/AIDS drug development and treatment (8 papers) and Inhalation and Respiratory Drug Delivery (5 papers). The work is most often cited by research in Hepatology (350 citations), Epidemiology (313 citations) and Infectious Diseases (154 citations). Erik Mogalian has collaborated with scholars based in United States, Australia and New Zealand. Frequent co-authors include Anita Mathias, Diana M. Brainard, Polina German, Paul B. Myrdal, John McNally, John G. McHutchison, Kimberly L. Garrison, Brian Doehle, Anu Osinusi and Lingling Han. Their work appears in journals such as Annals of Internal Medicine, Clinical Infectious Diseases and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.